BELIEVE study to assess Bimagrumab as treatment for obesityVersanis Bio, a clinical-stage biopharmaceutical company advancing novel therapeutics for cardiometabolic diseases, has announced that...
Standardisation of OAGB is key to reducing surgical errors and ensuring consistent patient outcomes19 hours ago